Sarah Mulholland

South–West of England’s Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Shaney Barratt, Sarah Mulholland, Khaled Al Jbour et al. · Frontiers in Pharmacology · 2018 · 43 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +11

Specialist palliative care, psychology, interstitial lung disease (ILD) multidisciplinary team meeting: a novel model to address palliative care needs

Shaney Barratt, Michelle Morales, Toby Peter Speirs et al. · BMJ Open Respiratory Research · 2018 · 33 citations · Full text

Nursing, Internal Medicine, Integrated Care +14

Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study

Lavanya Raman, Iain Stewart, Shaney Barratt et al. · ERJ Open Research · 2022 · 33 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK

Giles Dixon, Samuel Hague, Sarah Mulholland et al. · ERJ Open Research · 2024 · 24 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives

S Zulfikar, Sarah Mulholland, Huzaifa Adamali et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 2020 · 19 citations · Full text

Medicine, Immunology, Pharmacology +6